ArticleCancer immunology, immunotherapy : CII2016

Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.

Shinjiro Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.